FI902700A0 - Vaevnadplasminogenaktivatorderivat. - Google Patents

Vaevnadplasminogenaktivatorderivat.

Info

Publication number
FI902700A0
FI902700A0 FI902700A FI902700A FI902700A0 FI 902700 A0 FI902700 A0 FI 902700A0 FI 902700 A FI902700 A FI 902700A FI 902700 A FI902700 A FI 902700A FI 902700 A0 FI902700 A0 FI 902700A0
Authority
FI
Finland
Prior art keywords
vaevnadplasminogenaktivatorderivat
glycosylated
derivative
image
acid sequence
Prior art date
Application number
FI902700A
Other languages
English (en)
Other versions
FI101475B (fi
FI101475B1 (fi
Inventor
Anne Stern
Ulrich Kohnert
Rainer Rudolph
Stephen Fischer
Ulrich Martin
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI902700A0 publication Critical patent/FI902700A0/fi
Application granted granted Critical
Publication of FI101475B publication Critical patent/FI101475B/fi
Publication of FI101475B1 publication Critical patent/FI101475B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI902700A 1989-05-31 1990-05-30 Menetelmä kudosplasminogeeniaktivaattorijohdannaisen valmistamiseksi FI101475B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3917781 1989-05-31
DE3917781 1989-05-31
DE3923339A DE3923339A1 (de) 1989-05-31 1989-07-14 Gewebs-plasminogen-aktivator-derivat
DE3923339 1989-07-14

Publications (3)

Publication Number Publication Date
FI902700A0 true FI902700A0 (fi) 1990-05-30
FI101475B FI101475B (fi) 1998-06-30
FI101475B1 FI101475B1 (fi) 1998-06-30

Family

ID=25881452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902700A FI101475B1 (fi) 1989-05-31 1990-05-30 Menetelmä kudosplasminogeeniaktivaattorijohdannaisen valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0400545B1 (fi)
JP (1) JPH0327286A (fi)
AT (1) ATE119940T1 (fi)
AU (1) AU623781B2 (fi)
CA (1) CA2017636C (fi)
CZ (1) CZ267690A3 (fi)
DD (1) DD300109A5 (fi)
DE (2) DE3923339A1 (fi)
ES (1) ES2070210T3 (fi)
FI (1) FI101475B1 (fi)
HU (1) HU216870B (fi)
IE (1) IE66006B1 (fi)
IL (1) IL94539A (fi)
NO (1) NO902405L (fi)
NZ (1) NZ233796A (fi)
PT (1) PT94227B (fi)
ZA (1) ZA904089B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
US6027888A (en) * 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
FR2594845B1 (fr) * 1986-02-21 1989-12-01 Genetica Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
DE3643158A1 (de) * 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator(tpa) - derivat und seine herstellung
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat

Also Published As

Publication number Publication date
CZ282035B6 (cs) 1997-04-16
CA2017636C (en) 2000-05-02
ATE119940T1 (de) 1995-04-15
PT94227B (pt) 1997-01-31
NZ233796A (en) 1992-07-28
DE59008693D1 (de) 1995-04-20
IE901848L (en) 1990-11-30
HUT54734A (en) 1991-03-28
FI101475B (fi) 1998-06-30
CZ267690A3 (en) 1997-04-16
EP0400545B1 (de) 1995-03-15
AU5600990A (en) 1990-12-06
CA2017636A1 (en) 1990-11-30
FI101475B1 (fi) 1998-06-30
NO902405L (no) 1990-12-03
IE66006B1 (en) 1995-11-29
DE3923339A1 (de) 1990-12-06
AU623781B2 (en) 1992-05-21
EP0400545A1 (de) 1990-12-05
ES2070210T3 (es) 1995-06-01
JPH0327286A (ja) 1991-02-05
ZA904089B (en) 1991-03-27
DD300109A5 (de) 1992-05-21
HU903267D0 (en) 1990-10-28
IL94539A0 (en) 1991-03-10
IL94539A (en) 1996-08-04
PT94227A (pt) 1991-02-08
NO902405D0 (no) 1990-05-30
HU216870B (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
ES2043607T3 (es) Agentes fibrinoliticos modificados.
NO920703L (no) Fusjonsproteiner som omfatter gm-csf og il-3
SG139553A1 (en) 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
HU912739D0 (en) Stabilization of glycozylized tissue plasminogene activator (t-pa)
FI102970B1 (fi) Uusi ihmiskudostyyppinen plasminogeeni aktivaattori muunnelma
ZA891242B (en) 24r-scymnol,and preparation and use thereof
DE3879183D1 (de) Entladungselektrodenmaterial.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
NO912947L (no) Stabilisering av glykosylert t-pa.
NO910149L (no) Vevs-plasminogen-aktivator-analog.
DK7491A (da) Vaevsplasminogenaktivatoranalog
NO176345C (no) Todelt universal operasjonsbord
IE871856L (en) "modified tissue plasminogen activator"
GB8826692D0 (en) Tissue plasminogen activator
ITMI921866A1 (it) Uso dell'oxatomide come agente antitosse
CS93188A1 (en) The connection of source working with potential

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER MANNHEIM GMBH